Related Experiment Video
Updated: May 9, 2026

Quantification of Metal Leaching in Immobilized Metal Affinity Chromatography
Published on: January 17, 2020
Blood metal ion testing is an effectivescreening tool to identify poorly performing metal-on-metal bearingsurfaces
R P Sidaginamale1, T J Joyce, J K Lord
1Newcastle University, StephensonBuilding, Claremont Road, Newcastleupon Tyne NE1 7RU, UK.
Insights
Blood and serum metal ion levels, specifically cobalt (Co) and chromium (Cr), reliably indicate abnormal wear in metal-on-metal hip implants. Blood cobalt is a key indicator for detecting implant wear.
Area of Science:
- Biomaterials Science
- Orthopedic Surgery
- Clinical Chemistry
Background:
- Metal-on-metal (MoM) hip resurfacings can release chromium (Cr) and cobalt (Co) ions.
- Understanding background and implant-related metal ion levels is crucial for patient monitoring.
- The distribution of these ions in blood and serum requires further investigation.
Purpose of the Study:
- To establish baseline blood Cr and Co concentrations in a large cohort.
- To correlate blood/serum Cr and Co levels with retrieved MoM hip implants.
- To analyze the distribution and partitioning of Co and Cr ions in blood and serum.
Main Methods:
- Analysis of 3042 blood samples for Co and Cr.
- Volumetric wear assessment of 91 retrieved MoM hip devices.
- Linear regression and ROC curve analysis to evaluate ion reliability.
- Bland-Altman analysis and in vitro spiking studies to examine serum vs. whole blood partitioning.
Main Results:
- Blood Co and Cr concentrations effectively indicate abnormal implant wear.
- Blood cobalt levels of 4.5 µg/l demonstrated 94% sensitivity and 95% specificity for detecting abnormal wear.
- Metal ions preferentially accumulate in the serum compartment, both in vivo and in vitro.
Conclusions:
- Blood and serum metal ion concentrations serve as reliable biomarkers for abnormal wear in MoM hip arthroplasties.
- Significant differences exist in ion distribution between blood fractions and elements.
- Future clinical guidelines should account for these element- and fraction-specific differences.
Objectives:
The aims of this piece of work were to: 1) record the background concentrations of blood chromium (Cr) and cobalt (Co) concentrations in a large group of subjects; 2) to compare blood/serum Cr and Co concentrations with retrieved metal-on-metal (MoM) hip resurfacings; 3) to examine the distribution of Co and Cr in the serum and whole blood of patients with MoM hip arthroplasties; and 4) to further understand the partitioning of metal ions between the serum and whole blood fractions.
Methods:
A total of 3042 blood samples donated to the local transfusion centre were analysed to record Co and Cr concentrations. Also, 91 hip resurfacing devices from patients who had given pre-revision blood/serum samples for metal ion analysis underwent volumetric wear assessment using a coordinate measuring machine. Linear regression analysis was carried out and receiver operating characteristic curves were constructed to assess the reliability of metal ions to identify abnormally wearing implants. The relationship between serum and whole blood concentrations of Cr and Co in 1048 patients was analysed using Bland-Altman charts. This relationship was further investigated in an in vitro study during which human blood was spiked with trivalent and hexavalent Cr, the serum then separated and the fractions analysed.
Results:
Only one patient in the transfusion group was found to have a blood Co > 2 µg/l. Blood/Serum Cr and Co concentrations were reliable indicators of abnormal wear. Blood Co appeared to be the most useful clinical test, with a concentration of 4.5 µg/l showing sensitivity and specificity for the detection of abnormal wear of 94% and 95%, respectively. Generated metal ions tended to fill the serum compartment preferentially in vivo and this was replicated in the in vitro study when blood was spiked with trivalent Cr and bivalent Co.
Conclusions:
Blood/serum metal ion concentrations are reliable indicators of abnormal wear processes. Important differences exist however between elements and the blood fraction under study. Future guidelines must take these differences into account.
Related Concept Videos
Effects of EDTA on End-Point Detection Methods
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Qualitative Analysis
For instance, group IV...
EDTA: Direct, Back-, and Displacement Titration
Direct titration involves buffering the metal ion solution to the desired pH and directly titrating with standard EDTA until the endpoint. The optimum pH ensures a large conditional formation constant of metal−EDTA and visibility of the free indicator color in the solution. In addition, auxiliary complexing reagents are used to prevent the precipitation of metal hydroxides and...
Complexometric Titration: Overview

